Pam3CSK4

CAS No. 112208-00-1

Pam3CSK4( Pam3Cys-Ser-(Lys)4 )

Catalog No. M29767 CAS No. 112208-00-1

Pam3CSK4 is a synthetic triacylated lipopeptide (LP) that mimics the acylated amino terminus of bacterial LPs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    Pam3CSK4
  • Note
    Research use only, not for human use.
  • Brief Description
    Pam3CSK4 is a synthetic triacylated lipopeptide (LP) that mimics the acylated amino terminus of bacterial LPs.
  • Description
    Pam3CSK4 is a synthetic triacylated lipopeptide (LP) that mimics the acylated amino terminus of bacterial LPs.(In Vitro):Pam3CSK4 is a TLR1/2 heterodimer recognises triacylated lipopeptides. Pam3CSK4 (1 μg/mL) enhances the antibacterial functions of granulocyte macrophage-colony stimulating factor (GM-CSF) induced neutrophils to Methicillin-resistant Staphylococcus aureus.(In Vivo):Pam3CSK4 (5 mg/kg; i.p.; once a day for 9 days) alters brain, spleen and liver weights in neonatal mice.
  • In Vitro
    Pam3CSK4 is a TLR1/2 heterodimer recognises triacylated lipopeptides.Pam3CSK4 (1 μg/mL) enhances the antibacterial functions of granulocyte macrophage-colony stimulating factor (GM-CSF) induced neutrophils to Methicillin-resistant Staphylococcus aureus.
  • In Vivo
    Pam3CSK4 (5 mg/kg; i.p.; once a day for 9 days) alters brain, spleen and liver weights in neonatal mice. Animal Model:Time-mated pregnant C57BL/6 wild-type mice; B6.129-Tlr2tm1Kir/J (TLR2 -deficient) miceDosage:5 mg/kg Administration:Intraperitoneally (i.p.); once a day for 9 days Result:After repeated administration from postnatal day (PND3) to PND11, brain weight was decreased compared with endotoxin-free saline-treated animals at PND12. Decreased volume of cerebral gray matter, white matter in the forebrain and cerebellar molecular layer that was accompanied by an increase in spleen and liver weight at PND12.
  • Synonyms
    Pam3Cys-Ser-(Lys)4
  • Pathway
    Immunology/Inflammation
  • Target
    TLR
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    112208-00-1
  • Formula Weight
    1510.23
  • Molecular Formula
    C81H156N10O13S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Sequence:{Pam3Cys}-Ser-Lys-Lys-Lys-Lys

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Irvine KL, et al. The molecular basis for recognition of bacterial ligands at equine TLR2, TLR1 and TLR6. Vet Res. 2013 Jul 4;44:50.
molnova catalog
related products
  • CU-CPT22

    CU-CPT22 is the first probe for the complex between toll-like receptors TLR1 and TLR2.?CU-CPT22 binds at the interface of TLR1 and TLR2 (IC50 = 0.58 μM).?It competes with the synthetic triacylated lipoprotein (Pam3CSK4) binding to TLR1/2 (Ki: 0.41 μM).?

  • CU-CPT9b

    CU-CPT9b is an antagonist of toll-like receptor 8 (TLR8;?Kd = 21 nM).?It inhibits activation of NF-?B induced by the TLR8 agonist R-848 in TLR8-overexpressing HEK-Blue cells with an IC50 value of 0.7 nM.

  • CU-CPD107

    CU-CPD107 is a selective agonist of toll-like receptor 8 (TLR8) and also shows activation activity against ssRNA ligands. CU-CPD107 acts as an inhibitor of TLR8 signaling in the presence of R848 (IC50=13.7 μM).